The isolation of tetrangomycin from terrestrial Streptomyces sp CAH29: evaluation of antioxidant, anticancer, and anti-MRSA activity
dc.contributor.author | Ozakin, Suleyman | |
dc.contributor.author | Davis, Robert W. | |
dc.contributor.author | Umile, Thomas P. | |
dc.contributor.author | Pirinccioglu, Necmettin | |
dc.contributor.author | Kizil, Murat | |
dc.contributor.author | Celik, Gurbet | |
dc.contributor.author | Sen, Alaattin | |
dc.date.accessioned | 2024-04-24T15:59:43Z | |
dc.date.available | 2024-04-24T15:59:43Z | |
dc.date.issued | 2016 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | A rhizosphere isolate Streptomyces sp. CAH29 was found to possess potent antibacterial and antifungal activity against a variety of test organisms. Based on 16S ribosomal ribonucleic acid sequence homology studies, this strain was found to be similar to Streptomyces stramineus (gene sequence similarity 99 %). The major bioactive metabolite produced by Streptomyces sp. CAH29 isolate was extracted, purified andidentified by nuclear magnetic resonance as tetrangomycin. This known anthraquinone-exhibited antimicrobial activity against Staphylococcus aureus, Streptococcus pyogenes, methicillin resistant Staphylococcus aureus and Candida albicans with inhibition zones of 14, 10, 12 and 8 mm, respectively. Docking results demonstrate that tetrangomycin has a similar mode of action and a comparable docking score to bind to the dehydrosqualene synthase (CrtM) enzyme of methicillin resistant Staphylococcus aureus compared to the current inhibitor. Hence, this suggests that tetrangomycin has a potential to be used as an anti-methicillin resistant Staphylococcus aureus agent. Tetrangomycin also showed moderate free radical scavenging activity with 1,1-diphenyl-2-picryl-hydrazil. Tetrangomycin apparently decreased all of the studied cytokine (pro-inflammatory: interleukin 1B, interleukin 2, tumor necrosis factor and interleukin L6 and anti-inflammatory: interleukin 10) expression levels at IC50 concentrations in A459 (adenocarcinomic human alveolar basal epithelial) and LNCAP (human prostate adenocarcinoma) cell lines. In addition, it reduced Caspase 8 and 3 mRNA levels in LNCAP and A549 cells. This study describes for the first time novel in vitro immunosuppressive function of tetrangomycin by reducing the transcription of cytokine genes. | en_US |
dc.description.sponsorship | Scientific and Technical Research Council of Turkey [TBAG 109T843]; Dicle University Research Foundation [DUBAP-09-FF-45]; United States National Science Foundation [DEB-1136662] | en_US |
dc.description.sponsorship | This study was supported by the Scientific and Technical Research Council of Turkey (TBAG 109T843) and Dicle University Research Foundation (DUBAP-09-FF-45) as well as the United States National Science Foundation (DEB-1136662). The authors would like to thank the staff of the Princeton University NMR and Mass Spectrometry facilities for experimental support. | en_US |
dc.identifier.doi | 10.1007/s00044-016-1708-6 | |
dc.identifier.endpage | 2881 | en_US |
dc.identifier.issn | 1054-2523 | |
dc.identifier.issn | 1554-8120 | |
dc.identifier.issue | 12 | en_US |
dc.identifier.scopus | 2-s2.0-84984914909 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.startpage | 2872 | en_US |
dc.identifier.uri | https://doi.org/10.1007/s00044-016-1708-6 | |
dc.identifier.uri | https://hdl.handle.net/11468/14224 | |
dc.identifier.volume | 25 | en_US |
dc.identifier.wos | WOS:000387329600011 | |
dc.identifier.wosquality | Q4 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.language.iso | en | en_US |
dc.publisher | Springer Birkhauser | en_US |
dc.relation.ispartof | Medicinal Chemistry Research | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Streptomyces | en_US |
dc.subject | Angucylines | en_US |
dc.subject | Tetrangomycin | en_US |
dc.subject | Antimicrobial Activity | en_US |
dc.subject | Anti-Mrsa | en_US |
dc.subject | Cytotoxic Activity | en_US |
dc.subject | Immunosuppressive Activity | en_US |
dc.title | The isolation of tetrangomycin from terrestrial Streptomyces sp CAH29: evaluation of antioxidant, anticancer, and anti-MRSA activity | en_US |
dc.title | The isolation of tetrangomycin from terrestrial Streptomyces sp CAH29: evaluation of antioxidant, anticancer, and anti-MRSA activity | |
dc.type | Article | en_US |